Skip to content

Large Burn Outcome Study

Assessment of the Treatment of the Severely Burned With Anabolic Agents on Improved Wound Healing, Recovery and Rehabilitation: Large Burn Outcome Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00731887
Acronym
LBO
Enrollment
0
Registered
2008-08-11
Start date
2011-06-30
Completion date
2011-06-30
Last updated
2014-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Keywords

Burn injury, Burn recovery

Brief summary

To examine long term physical and psychosocial outcomes of pediatric burn survivors. We want to learn about thoughts, feelings, coping style, social support, and overall adjustment following burn injury.

Detailed description

To evaluate the long term quality of life of adolescents and adults who suffered severe pediatric burns. This study will include an array of physical and psychosocial assessments, thus providing a unique and complete set of information on the long term outcomes in this population.

Interventions

PROCEDUREBlood and urine testing

complete blood count, routine chemistries, liver function test, retinol binding protein, transferrin, prothrombin time, partial thromboplastin time, fibrinogen, Vitamin A and Zinc, Insulin Growth Factor levels and binding proteins, cytokines (interleukins 1, 6, 12), insulin, thyroid hormones, cortisol, 25-hydroxyvitamin D, and osteocalcin.

Sponsors

U.S. Department of Education
CollaboratorFED
Shriners Hospitals for Children
CollaboratorOTHER
The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 60% third degree total body surface area * Acute burn treatment at Shriners Burns Hospital for Children - Galveston between 1986-2005 * Three years post injury * Current age of at least 16 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026